164 related articles for article (PubMed ID: 25813058)
1. Cryptogenic stroke: clinical consideration of a heterogeneous ischemic subtype.
Scullen TA; Monlezun DJ; Siegler JE; George AJ; Schwickrath M; El Khoury R; Cho MC; Martin-Schild S
J Stroke Cerebrovasc Dis; 2015 May; 24(5):993-9. PubMed ID: 25813058
[TBL] [Abstract][Full Text] [Related]
2. Should all patients with mild ischemic stroke be excluded from therapeutic stroke trials?
Mittal M; Rymer M; Lai SM
J Clin Neurosci; 2012 Nov; 19(11):1486-9. PubMed ID: 22959447
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes after intravenous fibrinolysis in cryptogenic strokes with or without patent foramen ovale.
Chang JJ; Chiem T; Alderazi YJ; Chapple K; Restrepo L
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e492-9. PubMed ID: 23871701
[TBL] [Abstract][Full Text] [Related]
4. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
5. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.
Salam KA; Ummer K; Pradeep Kumar VG; Noone ML
Int J Stroke; 2014 Jun; 9(4):426-8. PubMed ID: 23981667
[TBL] [Abstract][Full Text] [Related]
6. Intravenous thrombolysis for acute ischemic stroke patients presenting with mild symptoms.
Strbian D; Piironen K; Meretoja A; Sairanen T; Putaala J; Tiainen M; Artto V; Rantanen K; Häppölä O; Kaste M; Lindsberg PJ;
Int J Stroke; 2013 Jul; 8(5):293-9. PubMed ID: 22568877
[TBL] [Abstract][Full Text] [Related]
7. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
Miedema I; Uyttenboogaart M; Koopman K; De Keyser J; Luijckx GJ
Cerebrovasc Dis; 2010 Feb; 29(3):263-7. PubMed ID: 20090317
[TBL] [Abstract][Full Text] [Related]
8. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the Predictive Validity of Etiologic Stroke Classification.
Arsava EM; Helenius J; Avery R; Sorgun MH; Kim GM; Pontes-Neto OM; Park KY; Rosand J; Vangel M; Ay H
JAMA Neurol; 2017 Apr; 74(4):419-426. PubMed ID: 28241214
[TBL] [Abstract][Full Text] [Related]
10. Impact of admission glucose and diabetes on recanalization and outcome after intra-arterial thrombolysis for ischaemic stroke.
Arnold M; Mattle S; Galimanis A; Kappeler L; Fischer U; Jung S; De Marchis GM; Gralla J; Mono ML; Brekenfeld C; Meier N; Nedeltchev K; Schroth G; Mattle HP
Int J Stroke; 2014 Dec; 9(8):985-91. PubMed ID: 22973986
[TBL] [Abstract][Full Text] [Related]
11. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
[TBL] [Abstract][Full Text] [Related]
12. [Stroke etiology and long-term need of care in ischemic stroke patients].
Dietl M; Pohle R; Weingärtner M; Polgar R; Grässel E; Schwab S; Kolominsky-Rabas P
Fortschr Neurol Psychiatr; 2009 Dec; 77(12):714-9. PubMed ID: 19950047
[TBL] [Abstract][Full Text] [Related]
13. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
[TBL] [Abstract][Full Text] [Related]
14. Etiological classifications of transient ischemic attacks: subtype classification by TOAST, CCS and ASCO--a pilot study.
Amort M; Fluri F; Weisskopf F; Gensicke H; Bonati LH; Lyrer PA; Engelter ST
Cerebrovasc Dis; 2012; 33(6):508-16. PubMed ID: 22538846
[TBL] [Abstract][Full Text] [Related]
15. Risk factors profile and clinical outcome of ischemic stroke patients admitted in a Department of Internal Medicine and classified by TOAST classification.
Pinto A; Tuttolomondo A; Di Raimondo D; Fernandez P; Licata G
Int Angiol; 2006 Sep; 25(3):261-7. PubMed ID: 16878074
[TBL] [Abstract][Full Text] [Related]
16. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for poor outcome and mortality at 3 months after the ischemic stroke in patients with atrial fibrillation.
Li S; Zhao X; Wang C; Liu L; Liu G; Wang Y; Wang C; Jing J; Wang YJ
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e419-25. PubMed ID: 23721617
[TBL] [Abstract][Full Text] [Related]
18. Safety and effectiveness of endovascular treatment after 6 hours of symptom onset in patients with anterior circulation ischemic stroke: a matched case control study.
Qureshi AI; Miley JT; Chaudhry SA; Semaan E; Rodriguez GJ; Suri MF; Adams HP
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1076-81. PubMed ID: 23099041
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Uric Acid Levels in Ischemic Stroke Patients.
Zhang X; Huang ZC; Lu TS; You SJ; Cao YJ; Liu CF
Neurotox Res; 2016 Jan; 29(1):10-20. PubMed ID: 26376636
[TBL] [Abstract][Full Text] [Related]
20. Revised iScore to predict outcomes after acute ischemic stroke.
Sung SF; Chen YW; Hung LC; Lin HJ
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1634-9. PubMed ID: 24709145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
